Search

everythinglearnresearchcommunity

for

Search:↓

Topical rapamycin may effectively treat fibrous papules on the face.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

A patient with complete hair loss regrew all her hair using tofacitinib.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.